EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small Molecule Compounds Inhibit Varicella-Zoster Virus Replication by Targeting the Portal Protein–Capsid Interface

Julius Svensmark iD, Emily Polk, Ellyn Kornfeind, Whitney Lane, Melissa A Visalli, Robert J Visalli

Viruses · 2025

DOI: 10.3390/v17111496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Julius Svensmark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA. Hauptthemen laut MEDLINE: Herpesvirus 3, Human, Virus Replication, Capsid Proteins, Antiviral Agents. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Mercer University Seed Funding, Mercer University School of Medicine Biomedical Sciences Masters Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Varicella-zoster virus (VZV) open reading frame 54 (ORF54) gene encodes an 87 kDa monomer that oligomerizes to form the pORF54 portal dodecamer. Located at a single viral capsid vertex, the portal facilitates the translocation of the newly synthesized viral genome into the preformed empty capsid. Previously described α-methylbenzyl thiourea compounds were shown to inhibit VZV DNA encapsidation, likely by targeting pORF54. In this study, drug resistant isolates were obtained via passage of VZV in increasing concentrations of one analog, Compound I (Comp I). Mutations identified in four compound resistant isolates (amino acids 48, 304, 324 and 407) all localized to a region of the portal that was predicted to interface with capsid proteins. The portal is known to undergo significant conformational changes at the portal–capsid interface during DNA encapsidation. A set of recombinant viruses was designed to reveal the chemical and physical importance of each of the resistance mutations at the portal–capsid interface, the proposed binding site of the compound series. In addition, we employed a novel complementing cell line to show that despite the presence of the portal in the virion, DNA encapsidation did not occur. We propose that a-methylbenzyl thiourea compounds perturb interactions at or near the portal–capsid interface and prevent conformational changes needed to support DNA encapsidation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 3, HumanVirus ReplicationCapsid ProteinsAntiviral AgentsCapsidHumansDrug Resistance, ViralCell LineMutation

Stichwörter der Autor:innen

DNA encapsidationVaricella-zoster virusantiviralsportal protein

Substanzen

Capsid ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
  • Department of Biological Sciences, Purdue University-Fort Wayne, Fort Wayne, IN 46805, USA.
  • Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA.

ORCID-Profile: Julius Svensmark

Förderung

  • NIH HHS
  • Mercer University Seed Funding
  • Mercer University School of Medicine Biomedical Sciences Masters Program
  • Mercer Undergraduate Biomedical Scholar (MUBS) Training Initiative
  • University of Alabama Start-Up Funding
  • National Institutes of Health
  • Mercer University Seed Funds
  • University of Alabama Start-Up funds

Zitieren

APA

Svensmark, J., Polk, E., Kornfeind, E., Lane, W., Visalli, M. A., & Visalli, R. J. (2025). Small Molecule Compounds Inhibit Varicella-Zoster Virus Replication by Targeting the Portal Protein–Capsid Interface. Viruses. https://doi.org/10.3390/v17111496

Vancouver

Svensmark J, Polk E, Kornfeind E, Lane W, Visalli MA, Visalli RJ. Small Molecule Compounds Inhibit Varicella-Zoster Virus Replication by Targeting the Portal Protein–Capsid Interface. Viruses. 2025. doi:10.3390/v17111496

BibTeX
@article{Svensmark2025,
  author = {Svensmark, Julius and Polk, Emily and Kornfeind, Ellyn and Lane, Whitney and Visalli, Melissa A and Visalli, Robert J},
  title = {Small Molecule Compounds Inhibit Varicella-Zoster Virus Replication by Targeting the Portal Protein–Capsid Interface},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17111496}
}
Kostenlos starten →